CONNETICS CORP
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CONNETICS CORP, 10-Q, EX-10.3, 2000-08-14
Next: COTELLIGENT INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE
SHEET, STATEMENT OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH 10-Q.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          31,580
<SECURITIES>                                    54,012
<RECEIVABLES>                                    1,351
<ALLOWANCES>                                         0
<INVENTORY>                                        444
<CURRENT-ASSETS>                                44,648
<PP&E>                                           4,851
<DEPRECIATION>                                   3,320
<TOTAL-ASSETS>                                  89,990
<CURRENT-LIABILITIES>                            8,108
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       157,266
<OTHER-SE>                                    (75,646)
<TOTAL-LIABILITY-AND-EQUITY>                    89,990
<SALES>                                          9,460
<TOTAL-REVENUES>                                23,753
<CGS>                                            1,799
<TOTAL-COSTS>                                    1,799
<OTHER-EXPENSES>                                21,693
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 169
<INCOME-PRETAX>                                    981
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       981
<EPS-BASIC>                                        .04
<EPS-DILUTED>                                      .03


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission